The results showed that in bladder urothelial carcinoma, rectal adenocarcinoma and endometrial carcinoma, patients with LRP2 mutations had significantly higher TMB than those without LRP2 mutations (Fig. S1A). Here, LRP2 is linked to endometrial carcinoma.